Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:


Last Updated: December 12, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Telcagepant

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What is the development status for investigational drug Telcagepant?

Telcagepant is an investigational drug.

There have been 11 clinical trials for Telcagepant. The most recent clinical trial was a Phase 3 trial, which was initiated on February 1st 2007.

The most common disease conditions in clinical trials are Migraine Disorders, Heart Diseases, and Coronary Disease. The leading clinical trial sponsors are Merck Sharp & Dohme Corp. and [disabled in preview].

Recent Clinical Trials for Telcagepant
Telcagepant for Prevention of Menstrually Related Migraine in Female Participants With Episodic Migraine (MK-0974-065)Merck Sharp & Dohme Corp.Phase 2/Phase 3
Positron Emission Tomography (PET) Study of Brain Calcitonin Gene-Related Peptide (CGRP) Receptor Occupancy After Telcagepant Administration (MK-0974-067)Merck Sharp & Dohme Corp.Phase 1
A Study to Test the Safety and Effectiveness of MK-0974 (Telcagepant) Co-administered With Ibuprofen or Acetaminophen in Patients With Migraines With or Without Aura (MK-0974-046)Merck Sharp & Dohme Corp.Phase 2

See all Telcagepant clinical trials

Clinical Trial Summary for Telcagepant

Top disease conditions for Telcagepant
Top clinical trial sponsors for Telcagepant

See all Telcagepant clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Express Scripts
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.